• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Onco360 Named National Pharmacy Partner for Itovebi™

    GLOBENEWSWIRE

    Publishes Ph 3 Results for Roche’s Itovebi in HR+ve Breast Cancer

    GLOBENEWSWIRE

    Genentech`s Itovebi (Inavolisib) Receives Approval in US

    FDA

    FDA Priority Review: Genentech`s Inavolisib For PIK3CA+ Breast Cancer

    BUSINESSWIRE

    FDA Priority Review: Roche`s Inavolisib For PIK3CA+ Breast Cancer

    GLOBENEWSWIRE

    FDA Grants Genentech`s Inavolisib Breakthrough For PIK3CA Breast Cancer

    BUSINESSWIRE

    FDA Grants Roche`s Inavolisib Breakthrough Therapy For PIK3CA Breast Cancer

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.